The highly frequent deficiency of MSH2/MSH6 or MSH6 expression in ovarian endometrioid carcinoma and OCCC, as opposed to the most MHL1/PMS2 expression deficiency in endometrial carcinoma [14, 31], indicates a high probability of LS. This evidence concerns the gene PMS2 and endometrial carcinoma.